Login

Brian Cox, CEO of SurgePays, Inc., discusses current $SURG developments at the technology and telecommunications company. 00:10:00

Share On Facebook Share On Twitter

Kevin Brian Cox. Chairman/CEO, SurgePays Inc ;

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Perpetual Expands Horizons: Acquisition of Trillium Asset Management | Rob Adams, CEO , Perpetual Limited .
00:10:00
"Celebrating Diversity and Achievement: Spotlight on Janus Henderson's Black Professional Network and Their Impact During Black History Month"
00:10:00
Bokusgruppen's CEO Maria Edsman and CFO Ola Maalsnes on Q4 2023 and Future Growth Prospects | Maria Edsman, CEO, Bokusgruppen AB.
00:10:00
Audrey Greenberg of Center for Breakthrough Medicines discusses investments with Mike Dever of Brandywine Asset Management.
00:10:00
Mount Milligan: Copper-Gold Open-Pit Mine in BC | Paul Tomory, President and Chief Executive Officer of Centerra Gold Inc.
00:10:00
Midnight Sun Mining: Developing Copper-Cobalt Deposits in Zambia
00:10:00
Xanadu Mines: Unearthing Mongolia's Copper and Gold Potential
00:10:00
Keith Anderson, President & CEO, Silver Sands: Overview of Silver Sands at One-to-One Mining Conference
00:10:00
Weekly Economic Update: Strong Market Performance Despite Modest Data
00:10:00
Current Trends and Future Prospects in the European Fundraising Market: A Conversation with Gordon Binet | Gordon Bajnai, Chairman , Campbell Lutyens.
00:10:00
Base Resources: Scaling Up Mineral Sands Operations in Africa and Madagascar at One-to-One Mining Conference
00:10:00
Proact President & CEO Jonas Hasselberg discusses the company's strategic vision, growth, and innovation in a fireside chat.

© 2026 Nehu